{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:04:36Z","timestamp":1795043076654,"version":"4.10.2"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK090728"],"award-info":[{"award-number":["P30DK090728"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K01DK110136"],"award-info":[{"award-number":["K01DK110136"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","award":["206g16a"],"award-info":[{"award-number":["206g16a"]}],"id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n                    <jats:title>Significance Statement<\/jats:title>\n                    <jats:p>Because renal function often remains stable in the early stages of autosomal dominant polycystic kidney disease (ADPKD), total kidney volume (TKV) is the most important biomarker of disease severity and progression. The authors developed and validated a fully automated method of simultaneously measuring TKV and total liver volume (TLV) as well as their growth rates from magnetic resonance images. Their findings indicate that the method\u2019s performance is equivalent to the gold standard of manual tracing while requiring a fraction of the time and skill. This approach may address the unmet need for rapid and reliable assessment of TKV and TLV, allowing identification of patients with rapidly progressing ADPKD for emerging drug treatments and serving as a reliable alternative for assessment of disease progression in clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The formation and growth of cysts in kidneys, and often liver, in autosomal dominant polycystic kidney disease (ADPKD) cause progressive increases in total kidney volume (TKV) and liver volume (TLV). Laborious and time-consuming manual tracing of kidneys and liver is the current gold standard. We developed a fully automated segmentation method for TKV and TLV measurement that uses a deep learning network optimized to perform semantic segmentation of kidneys and liver.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used 80% of a set of 440 abdominal magnetic resonance images (T2-weighted HASTE coronal sequences) from patients with ADPKD to train the network and the remaining 20% for validation. Both kidneys and liver were also segmented manually. To evaluate the method\u2019s performance, we used an additional test set of images from 100 patients, 45 of whom were also involved in longitudinal analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TKV and TLV measured by the automated approach correlated highly with manually traced TKV and TLV (intraclass correlation coefficients, 0.998 and 0.996, respectively), with low bias and high precision (&lt;0.1%\u00b12.7% for TKV and \u22121.6%\u00b13.1% for TLV); this was comparable with inter-reader variability of manual tracing (&lt;0.1%\u00b13.5% for TKV and \u22121.5%\u00b14.8% for TLV). For longitudinal analysis, bias and precision were &lt;0.1%\u00b13.2% for TKV and 1.4%\u00b12.9% for TLV growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings demonstrate a fully automated segmentation method that measures TKV, TLV, and changes in these parameters as accurately as manual tracing. This technique may facilitate future studies in which automated and reproducible TKV and TLV measurements are needed to assess disease severity, disease progression, and treatment response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.2018090902","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T16:25:12Z","timestamp":1562171112000},"page":"1514-1522","source":"Crossref","is-referenced-by-count":96,"title":["Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1681","volume":"30","author":[{"given":"Maatje D.A.","family":"van Gastel","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine;"},{"name":"Department of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie E.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Erickson","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron T.","family":"Gansevoort","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Kline","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine;"},{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"B1-20231016","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2215\/CJN.09500911","article-title":"Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.","volume":"7","author":"Chapman","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B2-20231016","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10157-013-0834-4","article-title":"Kidney volume and function in autosomal dominant polycystic kidney disease.","volume":"18","author":"Higashihara","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"B3-20231016","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease.","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"B4-20231016","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/ajkd.2002.33379","article-title":"Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study.","volume":"39","author":"Fick-Brosnahan","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"B7-20231016","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2215\/CJN.00080605","article-title":"Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: The consortium for radiologic imaging studies of polycystic kidney disease cohort.","volume":"1","author":"Bae","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8-20231016","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cgh.2014.07.051","article-title":"Liver involvement in early autosomal-dominant polycystic kidney disease.","volume":"13","author":"Hogan","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B9-20231016","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2017.11.024","article-title":"Clinical management of polycystic liver disease.","volume":"68","author":"van Aerts","year":"2018","journal-title":"J Hepatol"},{"key":"B10-20231016","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int"},{"key":"B11-20231016","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1681\/ASN.V1181505","article-title":"Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease.","volume":"11","author":"King","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"B12-20231016","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s10278-017-9978-1","article-title":"Performance of an artificial multi-observer deep neural network for fully automated segmentation of polycystic kidneys.","volume":"30","author":"Kline","year":"2017","journal-title":"J Digit Imaging"},{"key":"B13-20231016","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1053\/j.ajkd.2013.10.011","article-title":"Rationale and design of the DIPAK 1 study: A randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease.","volume":"63","author":"Meijer","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B14-20231016","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.ajkd.2015.06.017","article-title":"Estimation of total kidney volume in autosomal dominant polycystic kidney disease.","volume":"66","author":"Spithoven","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B15-20231016","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.2018.15870","article-title":"Effect of lanreotide on kidney function in patients with autosomal dominant polycystic kidney disease: The DIPAK 1 randomized clinical trial.","volume":"320","author":"Meijer","year":"2018","journal-title":"JAMA"},{"key":"B16-20231016","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"B17-20231016","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: A simple model for selecting patients for clinical trials.","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B18-20231016","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s13244-017-0558-1","article-title":"Liver segmentation: Indications, techniques and future directions.","volume":"8","author":"Gotra","year":"2017","journal-title":"Insights Imaging"},{"key":"B19-20231016","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/ckj\/sfy078","article-title":"Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney disease.","volume":"12","author":"Edwards","year":"2018","journal-title":"Clin Kidney J"},{"key":"B20-20231016","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00261-017-1285-2","article-title":"T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease.","volume":"43","author":"van Gastel","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"B21-20231016","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.1088\/0031-9155\/61\/22\/7864","article-title":"Automated segmentation of liver and liver cysts from bounded abdominal MR images in patients with autosomal dominant polycystic kidney disease.","volume":"61","author":"Kim","year":"2016","journal-title":"Phys Med Biol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201908000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:22:02Z","timestamp":1786130522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201908000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2018090902","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736131731.793562503","asserted-by":"object"}]},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,3]]}}}